Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTB4R | Q15722 | 7/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 1.00 |
| ▸ | NFKB1 | P19838 | 2/20 | 1.00 |
| ▸ | MTOR | P42345 | 1/20 | 1.00 |
| ▸ | PMP22 | Q01453 | 1/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 1/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 1/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 1.00 |
| ▸ | PLIN1 | O60240 | 1/20 | 1.00 |
| ▸ | GAA | P10253 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 1/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 1/20 | 1.00 |
| ▸ | PLIN5 | Q00G26 | 1/20 | 1.00 |
| ▸ | ABHD5 | Q8WTS1 | 1/20 | 1.00 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.39 |
| ▸ | FAAH | O00519 | 5/20 | 0.37 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10511272 | 1.00 | LTB4R (1.00) | LTB4RALDH1A1NFKB1MTORPMP22 | |
| SCHEMBL29462291 | 1.00 | LTB4R (1.00) | LTB4RALDH1A1NFKB1MTORPMP22 | |
| SCHEMBL10511276 | 1.00 | LTB4R (1.00) | LTB4RALDH1A1NFKB1MTORPMP22 | |
| SCHEMBL9237815 | 1.00 | LTB4R (1.00) | LTB4RALDH1A1NFKB1MTORPMP22 | |
| SCHEMBL9235257 | 0.88 | LTB4R (0.79) | LTB4RALDH1A1NFKB1MTORPMP22 | |
| SCHEMBL9235263 | 0.88 | LTB4R (0.79) | LTB4RALDH1A1NFKB1MTORPMP22 | |
| SCHEMBL9239472 | 0.88 | LTB4R (0.79) | LTB4RALDH1A1NFKB1MTORPMP22 | |
| SCHEMBL9237509 | 0.86 | LTB4R (0.75) | LTB4RALDH1A1NFKB1MTORPMP22 | |
| SCHEMBL9232710 | 0.86 | LTB4R (0.75) | LTB4RALDH1A1NFKB1MTORPMP22 | |
| SCHEMBL9235542 | 0.86 | LTB4R (0.75) | LTB4RALDH1A1NFKB1MTORPMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170333516-A1 | PREVENTIVE OR THERAPEUTIC AGENT FOR AGE-RELATED MACULAR DEGENERATION | JUNTENDO EDUCATIONAL FOUNDATION (JP) | 2017-11-23 | — | — | US | claimed |
| EP-3215146-B1 | BLT2 AGONISTS FOR THE TREATMENT OF PAIN | FRAUNHOFER GES FORSCHUNG (DE) | 2021-02-17 | — | — | EP | disclosed |
| US-10849954-B2 | Preventive or therapeutic agent for age-related macular degeneration | JUNTENDO EDUCATIONAL FOUNDATION (JP) | 2020-12-01 | — | — | US | disclosed |
| US-20190216790-A1 | Methods for Treating Pruritis | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2019-07-18 | — | — | US | disclosed |
| US-20170333516-A1 | PREVENTIVE OR THERAPEUTIC AGENT FOR AGE-RELATED MACULAR DEGENERATION | JUNTENDO EDUCATIONAL FOUNDATION (JP) | 2017-11-23 | — | — | US | disclosed |
| US-20170281575-A1 | BLT2 AGONISTS FOR THE TREATMENT OF PAIN | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2017-10-05 | — | — | US | disclosed |
| EP-3017813-A1 | BLT2 agonists for the treatment of pain | Fraunhofer Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2016-05-11 | — | — | EP | disclosed |
| US-20110105959-A1 | Novel Methods for Bone Treatment by Modulating an Arachidonic Acid Metabolic or Signaling Pathway | ACCELALOX, INC. (US) | 2011-05-05 | — | — | US | disclosed |
| US-20090280153-A1 | electrical devices, anti-scarring agents, and therapeutic compositions | ANGIOTECH INTERNATIONAL AG (CH) | 2009-11-12 | — | — | US | disclosed |
| US-20090226500-A1 | SUTURES AND ANTI-SCARRING AGENTS | ANGIOTECH PHARMACEUTICALS, INC (CA) | 2009-09-10 | — | — | US | disclosed |
| EP-1978930-A2 | SUTURES AND ANTI-SCARRING AGENTS | Angiotech Pharmaceuticals, Inc. (CA) | 2008-10-15 | — | — | EP | disclosed |
| WO-2007089878-A2 | SUTURES AND ANTI-SCARRING AGENTS | ANGIOTECH PHARMACEUTICALS, INC. (CA) | 2007-08-09 | — | — | WO | disclosed |
| WO-2006121522-A2 | IMPLANTABLE SENSORS AND PUMPS, ANTI-SCARRING AGENTS, AND THERAPEUTIC COMPOSITIONS | ANGIOTECH INTERNATIONAL AG (CH) | 2006-11-16 | — | — | WO | disclosed |
| WO-2006121518-A2 | ELECTRICAL DEVICES, ANTI-SCARRING AGENTS, AND THERAPEUTIC COMPOSITIONS | ANGIOTECH INTERNATIONAL AG (CH) | 2006-11-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10849954-B2 | Preventive or therapeutic agent for age-related macular degeneration | LTB4R, LTA4H, LTB4R2 | LTB4R 1/4885ALDH1A1 486/4885NFKB1 844/4885 |
| US-20190216790-A1 | Methods for Treating Pruritis | ITCH, CYSLTR2, CYSLTR1 | LTB4R 8/4885ALDH1A1 2690/4885NFKB1 1631/4885 |
| US-20170333516-A1 | PREVENTIVE OR THERAPEUTIC AGENT FOR AGE-RELATED MACULAR DEGENERATION | LTB4R, LTA4H, LTB4R2 | LTB4R 1/4885ALDH1A1 486/4885NFKB1 844/4885 |
| US-20090226500-A1 | SUTURES AND ANTI-SCARRING AGENTS | COL1A1, COL2A1, COL14A1 | LTB4R 374/4885ALDH1A1 2866/4885NFKB1 722/4885 |
| US-20090280153-A1 | electrical devices, anti-scarring agents, and therapeutic compositions | GAP43, TNNC1, GJB2 | LTB4R 352/4885ALDH1A1 1855/4885NFKB1 2194/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.